- Home
- KEN vs OGN Comparison
KEN vs OGN Comparison
Compare KEN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEN
- OGN
- Stock Information
- Founded
- KEN 2014
- OGN 1923
- Country
- KEN Singapore
- OGN United States
- Employees
- KEN N/A
- OGN N/A
- Industry
- KEN Electric Utilities: Central
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- KEN Utilities
- OGN Health Care
- Exchange
- KEN Nasdaq
- OGN Nasdaq
- Market Cap
- KEN 2.3B
- OGN 2.7B
- IPO Year
- KEN N/A
- OGN N/A
- Fundamental
- Price
- KEN $46.96
- OGN $10.30
- Analyst Decision
- KEN
- OGN Buy
- Analyst Count
- KEN 0
- OGN 3
- Target Price
- KEN N/A
- OGN $17.33
- AVG Volume (30 Days)
- KEN 11.7K
- OGN 3.6M
- Earning Date
- KEN 08-08-2025
- OGN 10-30-2025
- Dividend Yield
- KEN 10.39%
- OGN 0.75%
- EPS Growth
- KEN N/A
- OGN N/A
- EPS
- KEN 9.36
- OGN 2.69
- Revenue
- KEN $774,304,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- KEN N/A
- OGN N/A
- Revenue Next Year
- KEN N/A
- OGN $0.79
- P/E Ratio
- KEN $4.85
- OGN $3.95
- Revenue Growth
- KEN 5.38
- OGN N/A
- 52 Week Low
- KEN $26.02
- OGN $8.01
- 52 Week High
- KEN $49.99
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- KEN 63.50
- OGN 56.23
- Support Level
- KEN $45.71
- OGN $10.52
- Resistance Level
- KEN $46.86
- OGN $11.29
- Average True Range (ATR)
- KEN 0.75
- OGN 0.32
- MACD
- KEN 0.43
- OGN -0.01
- Stochastic Oscillator
- KEN 94.15
- OGN 51.37
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.